XSMI.DE
Xtrackers Switzerland UCITS ETF 1D
Europe
EQUITY
Passive
MANAGEMENT STYLE
€ 1.7 B
ASSETS UNDER MGMT
30 bp
EXPENSES
Fund Basics
| Inception date | Jan 22, 2007 |
| Regulation | UCITS |
| Fund Website | link... |
| Distributions | |
| Currency | EUR |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ROCHE HOLDING AG-GENUSSCHEIN | 17.5 % |
| ROCHE HOLDING LTD | 17.5 % |
| NOVARTIS AG-REG | 15.4 % |
| NOVARTIS AG | 15.4 % |
| NESTLE SA-REG | 13.9 % |
| UBS GROUP AG | 8.6 % |
| ABB LTD. | 7.0 % |
| CIE FINANCIERE RICHEMON-BR A | 6.4 % |
| ZURICH FINANCIAL SERVICES AG | 6.1 % |
| LONZA GROUP AG-REG | 2.8 % |
Constituent Breakdown
| Number of holdings | 22 |
| Herfindahl-Hirschman Index | 1,531 |
| Wgt avg mkt cap (mns) | $172,695 |
| Large cap (>$10bn) | 95.6% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 128.5% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
SWITZERLAND | 128.5 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.7% | 12.0% | 13.7% | 11.2% | 9.4% | 7.8% | -- | 5.6% |
| Dividend Yield | 0.0% | 1.9% | 1.8% | 1.9% | 2.1% | 1.9% | -- | 1.1% |
| Total Returns | 7.7% | 13.9% | 15.5% | 13.0% | 11.5% | 9.7% | -- | 6.7% | Ann. Volatility | 10.2% | 18.6% | 15.2% | 14.0% | 14.0% | 14.6% | -- | 16.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.06 | 0% |
| MSCI EAFE | 0.28 | 6% |
| MSCI Emg Mkts | 0.16 | 2% |
Liquidity Measures
| Avg. volume (000) | 14 |
| ADV traded (mns) | $2 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.00% |
Technical Indicators
| 30d moving avg. (EMA) | $152.30 |
| Relative strength (RSI) | 71 |
| MACD/Signal | 2.59/2.34 |
| Bollinger Bands (Upper/Lower) | $159.26/$147.79 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XSMI.DE |
Expenses vs. XSMI.DE |
ALTAR Score™ vs. XSMI.DE |
|---|---|---|---|---|
| XSMC.SW | Xtrackers Switzerland UCITS ETF 1C | 126.9% | 0 bp | -0.1% |
| XSLI.DE | Xtrackers SLI UCITS ETF 1D | 89.4% | -5 bp | -0.1% |
| XSDR.DE | Xtrackers MSCI Europe Health Care Screened UCITS ETF 1C | 70.8% | -13 bp | +0.4% |
| C030.DE | Amundi DJ Switzerland Titans 30 UCITS ETF Dist | 62.9% | -5 bp | -0.7% |
| XZEC.DE | Xtrackers Stoxx European Market Leaders UCITS ETF 1C | 31.9% | -5 bp | +0.2% |
| XZDE.DE | Xtrackers MSCI Europe High Dividend Yield ESG UCITS ETF 1D | 24.7% | -5 bp | +1.5% |
| XUEK.L | Xtrackers S&P Europe ex UK UCITS ETF 1D | 21.6% | -21 bp | +0.7% |
| ESIH.L | iShares MSCI Europe Health Care Sector UCITS ETF | 20.5% | -12 bp | +0.5% |
| EXV4.DE | iShares STOXX Europe 600 Health Care UCITS ETF (DE) | 19.9% | +16 bp | +0.2% |
| XZEP.DE | Xtrackers MSCI Europe ESG UCITS ETF 1D | 19.2% | -12 bp | +0.4% |
Risk and Returns: XSMI.DE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (EUR)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.4%
ALTAR SCORE™
29th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 239 funds in the Europe Equity category with an average
ALTAR Score™ of 7.2% and a standard deviation
of 1.3%. XSMI.DE's ALTAR Score™ is approximately -0.6 standard
deviations above the category average. This places XSMI.DE in the 29th percentile
among funds in the category.
Sell-Side Consensus
€161.66
PRICE TARGET
+10.9%
UPSIDE